Search results for "Intramuscular"

showing 4 items of 64 documents

Effects of strength and endurance training on thigh and leg muscle mass and composition in elderly women

1995

The effects of 18 wk of intensive strength and endurance training on knee extensor, knee flexor, and lower leg muscle mass and composition were studied in 76- to 78-yr-old women. Muscle cross-sectional area (CSA), lean tissue CSA, and relative proportion of fat were determined using computed tomography. The strength-trained women increased their total muscle lean tissue CSA of the thigh (1.5%; P = 0.035), quadriceps CSA (4.5%; P = 0.021), quadriceps lean tissue CSA (5.8%, P = 0.009), and mean Hounsfield unit of the lower leg muscles (11.2%; P = 0.035) compared with the changes that occurred in the control group during the experiment. The change in quadriceps lean tissue CSA because of the …

medicine.medical_specialtyWeight LiftingPhysiologyStrength trainingPhysical exerciseWalkingThighLeg muscleEndurance trainingPhysiology (medical)medicineHumansMuscle SkeletalExerciseAgedLegPhysical Education and TrainingKnee extensorsbusiness.industryOrgan SizeSurgerymedicine.anatomical_structureThighAnesthesiaBody CompositionPhysical EnduranceFemaleIntramuscular fatTomography X-Ray ComputedbusinessKnee flexorJournal of Applied Physiology
researchProduct

Premedication with midazolam in intellectually disabled dental patients: Intramuscular or oral administration? A retrospective study

2016

Background: The use of midazolam for dental care in patients with intellectual disability is poorly documented. The purpose of this study was to determine which method of premedication is more effective for these patients, 0.15 mg/kg of intramuscular midazolam or 0.3 mg/kg of oral midazolam. Material and Methods: This study was designed and implemented as a non-randomized retrospective study. The study population was composed of patients with intellectual disability who required dental treatment under ambulatory general anesthesia from August 2009 through April 2013. Patients were administered 0.15 mg/kg of midazolam intramuscularly (Group IM) or 0.3 mg/kg orally (Group PO). The predictor v…

medicine.medical_specialtygenetic structuresSedationMidazolamAdministration OralOdontologíaAnesthesia GeneralInjections Intramuscular03 medical and health sciences0302 clinical medicine030202 anesthesiologyOral administrationmedicineHumansHypnotics and SedativesDisabled PersonsDental CareGeneral DentistryRetrospective Studiesbusiness.industryResearchRetrospective cohort study030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Medically compromised patients in DentistryCiencias de la saludDental careSurgeryOtorhinolaryngologyAnesthesiaUNESCO::CIENCIAS MÉDICASAmbulatoryMidazolamPopulation studySurgeryPremedicationmedicine.symptombusinessmedicine.drugMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Cis-diaminedichloro platinum ototoxicity. An experimental study.

1985

Four groups of guinea pigs received different doses of cis-platinum. SEM and TEM showed a direct relation between the dose and the damage. The first row of OHC is the first one to be damaged. The IHC are more resistant than the OHC. The pattern of destruction is similar to the one produced by the aminoglucoside antibiotics.

medicine.medical_specialtymedicine.drug_classAntibioticsGuinea Pigschemistry.chemical_elementCis-platinumPharmacologyInjections IntramuscularOtotoxicityHair Cells AuditoryMedicineAnimalsHearing LossOrgan of Cortibusiness.industryGeneral Medicinemedicine.diseaseSurgeryMicroscopy Electronmedicine.anatomical_structureOtorhinolaryngologychemistryOrgan of CortiToxicityMicroscopy Electron ScanningKidney Diseasessense organsCisplatinbusinessPlatinumInjections IntraperitonealActa oto-laryngologica
researchProduct

Off-Adherence Keeping (OAK) observational study: intentional off-adherence immunomodulatory multiple sclerosis treatment

2022

Aims: To evaluate how improved treatment adherence with a lower-frequency regimen/treatment of intramuscular (IM) IFN beta-1a impacts therapeutic effectiveness in relapsing-remitting multiple sclerosis (MS) patients switching from a higher-frequency injectable regimen/treatment. Patients & methods: Italian patients with relapsing-remitting MS and prior poor adherence to high-frequency injectable treatments (n = 181) were followed for 24 months after starting IM IFN beta-1a. Results: During the study, 97.4% of patients were treatment adherent; 22.1% of patients reported a relapse. The estimated probability of remaining relapse-free after 2 years was 78%. A high dropout rate (52.5%) led t…

relapsesMultiple Sclerosis Relapsing-RemittingTreatment Outcomequality of lifeRecurrenceHumansSettore MED/26 - NeurologiaInterferon-betaNeurology (clinical)multiple sclerosistreatment adherenceInterferon beta-1aintramuscular interferon beta-1aNeurodegenerative Disease Management
researchProduct